StockWatch
·
Pharmaceutical Preparations
Business UpdateJul 15, 2026, 03:31 PM

BioHarvest Secures $1.4M IIA Grant for AI-Driven R&D Acceleration

AI Summary

BioHarvest Sciences Inc. announced it received a 4.33 million NIS (approximately $1.4 million USD) non-dilutive grant from the Israel Innovation Authority (IIA). This funding will accelerate the company's plant cell culture programs by integrating advanced data science, machine learning, and AI into its biological development workflows. This marks the second grant from the IIA this year, strengthening BioHarvest's financial position and transforming its early-stage R&D pipeline.

Key Highlights

  • BioHarvest received a $1.4 million (4.33 million NIS) non-dilutive grant from the Israel Innovation Authority (IIA).
  • The funding will accelerate plant cell culture programs by integrating advanced data science, machine learning, and AI.
  • The initiative aims to move from traditional trial-and-error R&D to a highly predictable, data-driven optimization framework.
  • The program will systematically predict plant cell propagation success and maximize active metabolite yields.
  • This is the second grant from the IIA this year, complementing a previous grant for manufacturing scaling.
  • The grant is a zero-interest loan, repayable solely from future revenues generated by the funded project.
  • No equity or equity-linked instruments were issued in connection with the grant.